Альфа-пвп: описание и особенности

Alpha-PVP is often sold as a 'designer drug' or disguised as plant fertilizer, bath salts, or research chemicals. Alpha-PVP is classified as a synthetic cathinone, part of the 'bath salts' family of designer drugs.

Hypokalemia (low potassium levels) has been observed in cases of Alpha-PVP intoxication. Its mechanism involves inhibiting the reuptake of dopamine (DAT) and norepinephrine (NET), leading to increased synaptic concentrations.

Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant. Alpha-PVP imports into New Zealand have been primarily from China and Pakistan since 2012.

Selective blockade of catecholamine transporters may increase addiction risk compared to non-selective substances.

Media reports claiming Alpha-PVP causes 'superhuman strength' or specific bizarre behaviors in all users are often sensationalized and not universally supported by clinical data. It was placed under a temporary nationwide ban in the United States effective February 2014.

Visual appearance often includes small white or bluish translucent crystals with a shiny surface. Alpha-PVP and its metabolites can be detected in blood and urine postmortem.

Rhabdomyolysis (muscle breakdown) has been reported in approximately 15% of clinical cases studied. Alpha-PVP is not explicitly scheduled under New Zealand's Misuse of Drugs Act but is controlled via structural similarity provisions.

Structural modifications, such as expanding the pyrrolidine ring to piperidine, significantly reduce potency at dopamine transporters.

Common clinical symptoms include mydriasis (dilated pupils), diaphoresis (excessive sweating), and seizures. Alpha-PVP is considered a parent compound or closely related to MDPV in structural lineage within the cathinone class.

Severe adverse effects include paranoia, agitation, hallucinations, delirium, and loss of motor control. It is specifically illegal in New South Wales, Australia, following fatal incidents involving users.

Research suggests Alpha-PVP may impair spatial learning and memory through brain mitochondrial dysfunction in animal models. Alpha-PVP fully substitutes for methamphetamine in rats trained to distinguish it from saline, though it is less potent than methamphetamine.

It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone).

Routes of administration include smoking, snorting (intranasal), injection, and oral ingestion. Clinical manifestations of intoxication often include tachycardia (observed in 92% of cases in one study), hypertension, and hyperthermia.

The European Union banned Alpha-PVP in 2015. Strong compulsive desire for re-dosing is a reported characteristic of Alpha-PVP use.

Acute effects in humans include euphoria, increased sociability, heightened libido, energy, and time distortion. Alpha-PVP was originally synthesized in the 1960s but did not enter widespread illicit use until the early 2000s.

Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'.